ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology

Through strategic collaboration with ProBio, Initium Therapeutics plans to utilize ProBio’s Berkeley Lights Beacon platform to expand their antibody drug pipeline.

Serving a Rising Power

ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded

ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC

ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program

ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes

Beroni Group Signs Agreement with ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

GenScript launches CDMO segment ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

GenScript launches CDMO segment ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation

GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma

GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation

Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center